Variations in cardiac procedures related to physician recommendations and hospital characteristics

December 12, 2011

Physician preferences and hospital characteristics influence the type of procedures performed on blockages of the heart, leading to significant variations in rates of bypass, stent or angioplasty procedures, found an article in CMAJ (Canadian Medical Association Journal).

There is significant variation in the ratio of percutaneous coronary interventions to coronary artery bypass graft surgeries (PCI:CABG ratio). Both procedures are performed to address blockages of coronary arteries. PCI procedures are less invasive than bypass surgery and were initially used to treat single-vessel heart disease. However, PCI is now used more widely for other conditions, including multivessel heart disease and multiple coronary issues. Rates for the procedure have increased in Ontario but there are indications that certain patients with multivessel disease have better long-term outcomes with CABG surgery than with PCI.

Canadian researchers analyzed data for 8972 patients who underwent diagnostic procedures -- cardiac catheterizations -- to look at heart function and any blockages or abnormalities in function, between April 2006 and March 2007 at 17 hospitals that perform cardiac procedures in Ontario. They wanted to understand the reason for the variations in the PCI:CABG ratio.

Coronary anatomy was the most important factor in PCI procedures being performed rather than CABG surgery but the recommendation for the procedure and the hospital where it was performed were also influential. The researchers found significant variation in the types of procedures offered, mostly among patients with multivessel disease.

"The variation was not primarily the result of differences in patient characteristics or the utilization of primary PCI (i.e., for emergent ST-segment elevation myocardial infarction [MI])," writes Dr. Jack Tu, Institute for Clinical Evaluative Sciences (ICES), with coauthors. "Rather, it appeared to reflect variations in treatment preferences and practice styles of the cardiologists performing the index catheterizations with regard to the management of patients with non-emergent multivessel disease, patients who could potentially be recommended for either PCI or CABG surgery."

"We found that the recommendation of the physician performing the diagnostic catheterization and the treating hospital were strong independent predictors of the mode of revascularization," write the authors.

The authors suggest changes that can lead to more consistency and transparency, such as creating multidisciplinary teams with the interventional cardiologist, a cardiac surgeon and referring physician, if possible. "Although many patients may still prefer PCI because it is less invasive, cardiac surgeons need to be more involved in clinical decision-making when patients are candidates for either PCI or CABG surgery. Patients need to be fully informed about the benefits and risks of all alternative treatment options," they conclude.

In a related commentary , Drs. David Holmes Jr. and Charanjit Rihal of the Mayo Clinic write that, for patients who could be recommended for either PCI or CABG, "the experience and training of the physician performing the angiography plays an important role. For example, an experienced interventional cardiologist trained in procedures to treat chronic total occlusion may recommend PCI, whereas a less experienced interventional cardiologist may favour surgical referral."

They conclude that the decision should be made based on the risks and benefits of all treatment options so that a patient may decide without being influenced by physician bias.
-end-


Canadian Medical Association Journal

Related Heart Articles from Brightsurf:

New 'atlas' of human heart cells first step toward precision treatments for heart disease
Scientists have for the first time documented all of the different cell types and genes expressed in the healthy human heart, in research published in the journal Nature.

Highly detailed map of the human heart could guide personalized heart treatments
Scientists have created a detailed cellular and molecular map of the healthy human heart to understand how this vital organ functions and to shed light on what goes awry in cardiovascular disease.

Highly detailed map of human heart could guide personalised heart treatments
Scientists have created the most detailed cellular and molecular map of the healthy human heart ever, to understand how the heart functions, and illuminate what goes wrong in cardiovascular disease.

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Machining the heart: New predictor for helping to beat chronic heart failure
Researchers from Kanazawa University have used machine learning to predict which classes of chronic heart failure patients are most likely to experience heart failure death, and which are most likely to develop an arrhythmic death or sudden cardiac death.

Molecular imaging identifies link between heart and kidney inflammation after heart attack
Whole body positron emission tomography (PET) has, for the first time, illustrated the existence of inter-organ communication between the heart and kidneys via the immune system following acute myocardial infarction.

New heart valve could transform open heart surgery for millions of patients globally
A new polymeric heart valve with a life span potentially longer than current artificial valves that would also prevent the need for the millions of patients with diseased heart valves to require life-long blood thinning tablets has been developed by scientists at the universities of Bristol and Cambridge.

Heart attacks, heart failure, stroke: COVID-19's dangerous cardiovascular complications
A new guide from emergency medicine doctors details the potentially deadly cardiovascular complications COVID-19 can cause.

Autoimmunity-associated heart dilation tied to heart-failure risk in type 1 diabetes
In people with type 1 diabetes without known cardiovascular disease, the presence of autoantibodies against heart muscle proteins was associated with cardiac magnetic resonance (CMR) imaging evidence of increased volume of the left ventricle (the heart's main pumping chamber), increased muscle mass, and reduced pumping function (ejection fraction), features that are associated with higher risk of failure in the general population

Digital heart model will help predict future heart health, new study finds
In recent times, researchers have increasing found that the power of computers and artificial intelligence is enabling more accurate diagnosis of a patient's current heart health and can provide an accurate projection of future heart health, potential treatments and disease prevention.

Read More: Heart News and Heart Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.